Completing the CE Mark submission for Eversense 365 brings us a step closer to improving lives and health outcomes for ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

The introduction of the continuous glucose monitor (CGM) made that unnecessary. The small device, typically attached to the arm, has a sensor under the skin that sends readings to an app on a ...

RESEARCHERS based in the USA have discovered that data from continuous glucose monitors (CGMs) can predict complications caused by Type 1 diabetes, including nerve damage, kidney disease, and vision ...

Individuals take a scientific, data-driven approach to understanding and optimising their bodies. Advanced tracking devices like continuous glucose monitors (CGM) are becoming extremely popular for ...

has seen a large boost to sales from strong demand for FreeStyle Libre - its continuous glucose monitor. Abbott had been facing supply issues for its Libre devices and said it will meet the demand ...

Once submitted, we will try and place you in contact with a suitable Blood Glucose Monitors supplier within 48 hours.

Data from continuous glucose monitors can predict nerve, eye and kidney damage caused by type 1 diabetes, University of Virginia Center for Diabetes Technology researchers have found. That suggests ...

RICHMOND, Va. (WRIC) — A research study from the University of Virginia Center for Diabetes Technology suggests that data from continuous glucose monitors (CGMs) can predict the development of ...